OCT 30, 2014 3:00 PM PDT

Probing cancer metabolism using isotope tracers to identify therapeutic targets

Speaker

Abstract

Oncogenic mutations in isocitrate dehydrogenase 1 (IDH1) or 2 (IDH2) compromise their normal activity and induce NADPH-dependent (D)2-hydroxyglutarate (2HG) production within the cytosol or mitochondria. Given the critical functions of these enzymes in tricarboxylic acid (TCA) metabolism and cellular redox homeostasis, such mutations are likely to cause metabolic reprogramming in tumors. To identify metabolic abnormalities in cells harboring IDH mutations we applied 13C metabolic flux analysis (MFA) to isogenic cells with heterozygous IDH1 mutations. MFA results indicate that IDH1 mutant cells exhibit increased oxidative TCA metabolism and oxygen consumption under hypoxia relative to parental cells. This metabolic phenotype occurs independently of 2HG accumulation and renders IDH1 mutant cells more sensitive to electron transport chain (ETC) inhibition compared to IDH wild-type and IDH2 mutant cells. These data suggest that targeting mitochondrial metabolism may be synthetically lethal in tumors expressing mutant IDH1 and can be combined with strategies that selectively inhibit its neomorphic activity.
In addition, we have exploited the NADPH-dependent 2HG production by mutant IDH1 and IDH2 to characterize the function of compartmentalized cofactor cycles that occur in cancer cells. Importantly, pathway segregation in distinct organelles has prevented traditional MFA approaches from accurately measuring fluxes within specific compartments. By applying 2H isotope tracers that specifically label NADPH and inducibly expressing IDH1-R132H or IDH2-R172K in the cytosol or mitochondria, respectively, we can reliably quantify NADPH metabolism in each compartment. Using this approach we have elucidated the directionality of metabolic cycles coordinated between the cytosol and mitochondria that are critical for tumor growth.

Learning objectives:

  • Why are mitochondria important for cancer cell growth?
  • Why would some cancers be more susceptible to cancer targeting than others?

Show Resources
You May Also Like
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
SEP 17, 2021 12:00 PM CST
C.E. CREDITS
SEP 17, 2021 12:00 PM CST
Date: September 16, 2021 Time: 9:00pm (PDT), 12:00am (EDT) 3D cellular models like organoids and spheroids offer an opportunity to better understand complex biology in a physiologically rele...
NOV 09, 2021 11:00 AM PST
C.E. CREDITS
NOV 09, 2021 11:00 AM PST
Date: November 09, 2021 Time: 11:00am (PDT), 02:00pm (EDT) Clinical translation of human pluripotent stem cells (hPSCs) requires advanced strategies that ensure safe and robust long-term gro...
JUN 24, 2021 10:00 AM PDT
C.E. CREDITS
JUN 24, 2021 10:00 AM PDT
Date: June 24, 2021 Time: 10:00am PDT The Chan Zuckerberg Initiative (CZI) was founded to help solve some of society’s toughest challenges— from eradicating disease and improving...
DEC 01, 2021 7:00 AM PST
C.E. CREDITS
DEC 01, 2021 7:00 AM PST
Date: December 01, 2021 Time: 7:00am (PST), 10:00am (EST) In the era of immuno-oncology, there is a growing need for the identification of new biomarkers predictive for sensitivity to anti-P...
OCT 21, 2021 9:00 AM PDT
C.E. CREDITS
OCT 21, 2021 9:00 AM PDT
Date: October 21, 2021 Time: 9:00am (PDT), 12:00pm (EDT) Industry guidelines for host cell protein impurity analysis emphasize the importance of process-specific and product-specific assessm...
OCT 30, 2014 3:00 PM PDT

Probing cancer metabolism using isotope tracers to identify therapeutic targets



Show Resources
Loading Comments...
Show Resources